항암제 과민반응에 대한 탈감작요법의 최신지견

키워드

참고문헌 (54)

1. Solensky R, "Drug hypersensitivity", Med Clin North Am, 90, pp.233~260 (2006)
2. Callahan MB, "Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer", Am J Obstet Gynecol, 197, pp.199~ (2007)
3. Smith IE, "Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer", Cancer Treat Rep, 69, pp.43~46 (1985)
4. Rothenberg ML, "Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial", J Clin Oncol, 21, pp.2059~2069 (2003)
5. Markman M, "Clinical features of hypersensitivity reactions to carboplatin", J Clin Oncol, 17, pp.1141~ (1999)
6. Siu SW, "Hypersensitivity reactions to oxaliplatin: experience in a single institute", Ann Oncol, 17, pp.259~261 (2006)
7. Syrigou E, "Hypersensitivity reactions to oxaliplatin and other antineoplastic agents", Curr Allergy Asthma Rep, 8, pp.56~62 (2008)
8. Lee C, "Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents", Ann Allergy Asthma Immunol, 102, pp.179~187 (2009)
9. Pagani M, "The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization", Med Clin North Am, 94, pp.835~852 (2010)
10. Lee CW, "Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell", IgE-mediated reactions, 2004, pp.95, 370~376
11. Lee CW, "Rapid inpatient", outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses, 2005, pp.99, 393~399
12. Cortijo-Cascajares S, "Effectiveness of oxaliplatin desensitization protocols", Clin Transl Oncol, 15, pp.219~225 (2013)
13. Garufi C, "Immunohemolytic anemia following oxaliplatin administration", Ann Oncol, 11, pp.497~ (2000)
14. Ichikawa Y, "Allergic reactions to oxaliplatin in a single institute in Japan", Jpn J Clin Oncol, 39, pp.616~620 (2009)
15. Castells MC, "Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases", J Allergy Clin Immunol, 122, pp.574~580 (2008)
16. Shaw JL, "IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps", Am J Respir Crit Care Med, 188, pp.432~439 (2013)
17. Meyer L, "Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule", J Clin Oncol, 20, pp.1146~1147 (2002)
18. Gammon D, "Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol", Oncologist, 9, pp.546~549 (2004)
19. Mis L, "Successful desensitization to oxaliplatin", Ann Pharmacother, 39, pp.966~969 (2005)
20. Nozawa H, "Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer", Clin Ther, 30, pp.1160~1165 (2008)
21. Wani MC, "Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia", J Am Chem Soc, 93, pp.2325~2327 (1971)
22. Yared JA, "Update on taxane development: new analogs and new formulations", Drug Des Devel Ther, 6, pp.371~384 (2012)
23. Rowinsky EK, "Paclitaxel (taxol)", N Engl J Med, 332, pp.1004~1014 (1995)
24. Rowinsky EK, "Clinical toxicities encountered with paclitaxel (Taxol)", Semin Oncol, 20(4 Suppl 3), pp.1~15 (1993)
25. Markman M, "An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions", J Cancer Res Clin Oncol, 125, pp.427~429 (1999)
26. Tankanow RM, "Docetaxel: a taxoid for the treatment of metastatic breast cancer", Am J Health Syst Pharm, 55, pp.1777~1791 (1998)
27. Markman M, "Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center", J Clin Oncol, 18, pp.102~105 (2000)
28. Peereboom DM, "Successful re-treatment with taxol after major hypersensitivity reactions", J Clin Oncol, 11, pp.885~890 (1993)
29. Berger MJ, "Feasibility of stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction", Support Care Cancer, 20, pp.1991~1997 (2012)
30. Schwartz JR, "Dexamethasone premedication for prophylaxis of taxane toxicities: can the doses be reduced when paclitaxel or docetaxel are given weekly?", J Oncol Pharm Pract, 18, pp.250~256 (2012)
31. Feldweg AM, "Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments", Gynecol Oncol, 96, pp.824~829 (2005)
32. Joerger M, "Prevention and handling of acute allergic and infusion reactions in oncology", Ann Oncol, 23, pp.313~319 (2012)
33. Gelderblom H, "the drawbacks and advantages of vehicle selection for drug formulation", Eur J Cancer, 37, pp.1590~1598 (2001)
34. Szebeni J, "Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions", Int Immunopharmacol, 1, pp.721~735 (2001)
35. Szebeni J, "Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study", J Natl Cancer Inst, 90, pp.300~306 (1998)
36. Weiszhár Z, "Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20", Eur J Pharm Sci, 45, pp.492~498 (2012)
37. Decorti G, "Effect of paclitaxel and Cremophor EL on mast cell histamine secretion and their interaction with adriamycin", Anticancer Res, 16, pp.317~320 (1996)
38. Gradishar WJ, "Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer", J Clin Oncol, 23, pp.7794~7803 (2005)
39. Essayan DM, "Successful parenteral desensitization to paclitaxel", J Allergy Clin Immunol, 97, pp.42~46 (1996)
40. Lokich J, "Paclitaxel hypersensitivity reactions: a role for docetaxel substitution", Ann Oncol, 9, pp.573~ (1998)
41. Denman JP, "Hypersensitivity reaction (HSR) to docetaxel after a previous HSR to paclitaxel", J Clin Oncol, 20, pp.2760~2761 (2002)
42. Fishman A, "Effective desensitization protocol to paclitaxel following hypersensitivity reaction", Int J Gynecol Cance, 9, pp.156~159 (1999)
43. Syrigou E, "Hypersensitivity reactions to docetaxel: retrospective evaluation and development of a desensitization protocol", Int Arch Allergy Immunol, 156, pp.320~324 (2011)
44. Gastaminza G, "A new rapid desensitization protocol for chemotherapy agents", J Investig Allergol Clin Immunol, 21, pp.108~112 (2011)
45. Sacks PL, "The impact of neo-osteogenesis on disease control in chronic rhinosinusitis after primary surgery", Int Forum Allergy Rhinol, 3, pp.823~827 (2013)
46. Syrigou E, "Hypersensitivity reactions to antineoplastic agents: an overview", Anticancer Drugs, 20, pp.1~6 (2009)
47. Bonno M, "Rapid desensitization for L-asparaginase hypersensitivity", J Allergy Clin Immunol, 101, pp.571~572 (1998)
48. Vrooman LM, "Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia", Pediatr Blood Cancer, 54, pp.199~205 (2010)
49. Akbayram S, "A desensitization protocol in children with L-asparaginase hypersensitivity", J Pediatr Hematol Oncol, 32, pp.187~191 (2010)
50. Farnam K, "Nonallergic drug hypersensitivity reactions", Int Arch Allergy Immunol, 159, pp.327~345 (2012)
51. Kidera Y, "High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin", Int J Clin Oncol, 16, pp.244~249 (2011)
52. Kim MY, "Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans", Asian Pac J Cancer Prev, 13, pp.1209~1215 (2012)
53. Castells M, "Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization", Cancer Immunol Immunother, 61, pp.1575~1584 (2012)
54. Makrilia N, "Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review", Met Based Drugs, pp.207084~ (2010)

관련 논문AI추천